Cell membrane structure stabilization

Cell membrane structure stabilization refers to a pharmacological effect and biological process characterized by the maintenance of the physical integrity and functional stability of cellular membranes (Islam et al., 2015; Hossain et al., 2014). It is not a single molecular target, such as a specific receptor or enzyme, but rather a functional outcome achieved through various mechanisms, including direct interaction with the lipid bilayer or stabilization of membrane-associated proteins (Heier et al., 2018; Debnath et al., 2013). This process is critical in preventing the premature rupture of cells, such as erythrocytes and mast cells, and the subsequent release of inflammatory mediators like histamine and lysosomal enzymes (Debnath et al., 2013; Seema et al., 2011). In therapeutic contexts, membrane stabilization is a primary mechanism for mast cell stabilizers used in allergy and asthma, as well as for certain steroids and surfactants used to treat muscular dystrophies where the membrane is inherently fragile (Heier et al., 2018; Seema et al., 2011). For example, drugs like Poloxamer 188 act as membrane sealants by inserting into damaged areas of the lipid bilayer to restore barrier function (Heier et al., 2018). Additionally, the membrane-stabilizing activity of certain local anesthetics and beta-blockers refers to their ability to decrease membrane excitability by interacting with ion channels. Because it represents a broad physiological effect, it is often evaluated using in vitro assays like the human red blood cell (HRBC) stabilization test to screen for anti-inflammatory potential (Islam et al., 2015; Hossain et al., 2014).

Other names

Membrane stabilizationMembrane stabilizing activityErythrocyte membrane stabilizationLysosomal membrane stabilization

Stabilization of the lipid bilayer to reduce fluidity, sealing of membrane pores, or inhibition of lysosomal enzyme release.